Healthpeak Properties, Inc. $DOC Shares Purchased by Davis Selected Advisers

Davis Selected Advisers raised its position in Healthpeak Properties, Inc. (NYSE:DOC) by 14.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 446,866 shares of the real estate investment trust’s stock after acquiring an additional 57,680 shares during the quarter. Davis Selected Advisers owned approximately 0.06% of Healthpeak Properties worth $8,557,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mather Group LLC. acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $25,000. City Holding Co. acquired a new position in shares of Healthpeak Properties during the third quarter worth $26,000. Rexford Capital Inc. purchased a new position in Healthpeak Properties in the second quarter valued at $28,000. Sound Income Strategies LLC purchased a new position in Healthpeak Properties in the third quarter valued at $28,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in Healthpeak Properties in the second quarter valued at $32,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of DOC opened at $17.40 on Thursday. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. Healthpeak Properties, Inc. has a 1-year low of $15.71 and a 1-year high of $20.81. The stock has a market cap of $12.10 billion, a PE ratio of 174.00, a price-to-earnings-growth ratio of 9.45 and a beta of 1.12. The firm has a fifty day moving average price of $17.24 and a 200 day moving average price of $17.56.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same quarter last year, the company posted $0.46 earnings per share. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 7.0%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 1,220.00%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. The Goldman Sachs Group initiated coverage on Healthpeak Properties in a research report on Friday, January 9th. They set a “neutral” rating and a $17.00 target price on the stock. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a research note on Monday, January 5th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $19.42.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.